President Donald Trump announced the launch of TrumpRx, a direct-to-consumer website to lower prescription drug costs in the U.S. The platform connects consumers to drugmakers offering discounts, targeting cash-paying patients. Lilly, Novo, and 14 others have agreements with the administration. The site features drugs from AstraZeneca, Lilly, EMD Serono, Novo Nordisk, and Pfizer. TrumpRx aims to expand access to affordable medications.
Concerns remain about actual savings from buying at direct-to-consumer prices. Discounts may not be significant compared to what insurers pay after rebates. Medicare and Medicaid already secure substantial discounts. Experts suggest that using insurance may provide better deals for most brand-name medications. TrumpRx offers discounts on popular drugs like Ozempic and Wegovy, emphasizing cash-pay options. Other drugs are expected to be listed on the platform. Key treatments from companies like Amgen, Merck, and Gilead are making waves in the healthcare industry. Bristol Myers Squibb CEO, Chris Boerner, expressed plans to expand their direct-to-consumer platform with cash-pay discounts. Boerner emphasized the need to simplify the healthcare system and reduce costs by utilizing direct-to-consumer models.
Eli Lilly CEO, Dave Ricks, revealed in an exclusive interview with CNBC that the company is leading the way in selling obesity treatments directly to patients. Ricks expressed support for TrumpRx’s efforts to expand direct-to-patient sales across the pharmaceutical industry. This initiative aims to make medications more accessible and affordable for consumers.
Read more at CNBC
1. The stock market experienced a sharp decline today, with the Dow Jones Industrial Average dropping 500 points due to concerns over inflation and rising interest rates.
2. The latest job report showed that the economy added 250,000 new jobs in the past month, exceeding expectations and indicating a strong labor market.
3. Tesla announced record-breaking sales for the third quarter, with over 240,000 vehicles delivered worldwide, surpassing analysts’ projections.: White House launches direct to consumer drug site